CPT 81443: Multi-Gene Genomic Sequencing Panel for Inherited Conditions
CPT code 81443 denotes a multi-gene genomic sequencing panel that assesses a patient specimen for genetic sequences across at least 15 genes linked to severe inherited conditions, including several genes with higher prevalence in individuals of Ashkenazi Jewish heritage. Nationally, molecular diagnostic panels like this shape genetic screening, carrier testing, and diagnostic pathways for inherited disorders and influence laboratory service utilization and payer coverage decisions. Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. This publication provides readers with a concise overview of what CPT code 81443 represents clinically and operationally, notes which major payers are included in the analysis, and outlines the topics covered: code definition and clinical context, typical sites of service and laboratory workflow implications, payer coverage landscape, and common billing considerations. The document summarizes how multi-gene sequencing panels are used in clinical genetics and carrier screening programs, highlights payer inclusion for national applicability, and identifies areas where policy language or coverage criteria commonly affect claims for such panels. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 81443 policy alerts
Get alerted when payer policies referencing 81443 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 81443 describes a genomic sequencing panel performed by a laboratory analyst that evaluates a patient specimen for genetic sequences across at least 15 genes. The panel includes genes associated with severe inherited conditions, with several genes commonly clustered in individuals of Ashkenazi Jewish descent. The assay is intended to detect pathogenic variants relevant to inherited genetic disorders.
Service Type: Genetic testing — multi-gene sequencing panel
Typical Site of Service: Clinical laboratory or outpatient specimen collection with testing performed in a certified molecular diagnostics laboratory
National Reimbursement Benchmarks
National commercial reimbursement for CPT 81443 centers near BUCA’s average commercial rate of $2,356.60, with substantial variation among major payers. Blue Cross Blue Shield shows the highest dispersion between its 25th and 75th percentiles (range $1,275.00), and Cigna and UnitedHealth Group also display wide interquartile spreads ($1,757.20 and $1,469.20 respectively), signaling notable regional or contract-level variability. Aetna’s interquartile range is narrower at $1,003.70, representing one of the tighter distributions among these payers.
In absolute terms, payer-level medians and means diverge: Blue Cross Blue Shield and Cigna have higher mean and median benchmarks relative to Aetna and UnitedHealth Group, while BUCA’s mean at $2,356.60 sits between those groups. The IQR comparison highlights where reimbursement is more predictable (Aetna) versus where it is more dispersed (Blue Cross Blue Shield, Cigna, UnitedHealth Group).